Works matching AU Bendell, Johanna

Results: 100

Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.

Published in:

2016

By:

Bendell, Johanna;
Patel, Manish;
Yoshida, Kenichiro;
Seraj, Jabed;
Weaver, Racquel;
Lemech, Charlotte;
Todaro, Thomas;
Pant, Shubham;
Arkenau, Hendrik-Tobias;
Bendell, Johanna C;
Patel, Manish R;
Todaro, Thomas G

Publication type:

journal article

A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.

Published in:

2016

By:

Burris, Howard;
Infante, Jeffrey;
Anthony Greco, F.;
Thompson, Dana;
Barton, John;
Bendell, Johanna;
Nambu, Yoshihiro;
Watanabe, Noriko;
Jones, Suzanne;
Burris, Howard A;
Infante, Jeffrey R;
Thompson, Dana S;
Barton, John H;
Bendell, Johanna C;
Jones, Suzanne F

Publication type:

journal article

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Published in:

2016

By:

Bendell, Johanna;
Rosen, Lee;
Mayer, Robert;
Goldman, Jonathan;
Infante, Jeffrey;
Benedetti, Fabio;
Lin, Donghu;
Mizuguchi, Hirokazu;
Zergebel, Christopher;
Patel, Manish;
Bendell, Johanna C;
Rosen, Lee S;
Mayer, Robert J;
Goldman, Jonathan W;
Infante, Jeffrey R;
Patel, Manish R

Publication type:

corrected article

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Published in:

2015

By:

Bendell, Johanna;
Rosen, Lee;
Mayer, Robert;
Goldman, Jonathan;
Infante, Jeffrey;
Benedetti, Fabio;
Lin, Donghu;
Mizuguchi, Hirokazu;
Zergebel, Christopher;
Patel, Manish;
Bendell, Johanna C;
Rosen, Lee S;
Mayer, Robert J;
Goldman, Jonathan W;
Infante, Jeffrey R;
Patel, Manish R

Publication type:

journal article

A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.

Published in:

2015

By:

Jones, Robin;
Bendell, Johanna;
Smith, David;
Diefenbach, Konstanze;
Lettieri, John;
Boix, Oliver;
Lockhart, A.;
O'Bryant, Cindy;
Moore, Kathleen;
Jones, Robin L;
Bendell, Johanna C;
Smith, David C;
Lockhart, A Craig;
Moore, Kathleen N

Publication type:

journal article

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.

Published in:

Oncology, 2018, v. 94, n. 6, p. 329, doi. 10.1159/000485384

By:

Thomas, Melanie B.;
Garrett-Mayer, Elizabeth;
Anis, Munazza;
Anderton, Kate;
Bentz, Tricia;
Edwards, Andie;
Brisendine, Alan;
Weiss, Geoffrey;
Siegel, Abby B.;
Bendell, Johanna;
Baron, Ari;
Duddalwar, Vinay;
El-Khoueiry, Anthony

Publication type:

Article

Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer.

Published in:

Oncology, 2009, v. 77, n. 3/4, p. 244, doi. 10.1159/000236048

By:

Chu, Edward;
Nianwen Shi;
Wenhui Wei;
Bendell, Johanna C.;
Cartwright, Thomas

Publication type:

Article

Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.

Published in:

Oncologist, 2022, v. 27, n. 11, p. 905, doi. 10.1093/oncolo/oyac174

By:

Powderly, John D;
Klempner, Samuel J;
Naing, Aung;
Bendell, Johanna;
Garrido-Laguna, Ignacio;
Catenacci, Daniel V T;
Taylor, Matthew H;
Lee, James J;
Zheng, Fred;
Zhou, Feng;
Gong, Xiaohua;
Gowda, Hema;
Beatty, Gregory L

Publication type:

Article

FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.

Published in:

Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642

By:

Pietrantonio, Filippo;
Fucà, Giovanni;
Rossini, Daniele;
Schmoll, Hans‐Joachim;
Bendell, Johanna C.;
Morano, Federica;
Antoniotti, Carlotta;
Corallo, Salvatore;
Borelli, Beatrice;
Raimondi, Alessandra;
Marmorino, Federica;
Niger, Monica;
Boccaccino, Alessandra;
Masi, Gianluca;
Lonardi, Sara;
Boni, Luca;
Braud, Filippo;
Di Bartolomeo, Maria;
Falcone, Alfredo;
Cremolini, Chiara

Publication type:

Article

Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.

Published in:

Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474

By:

Bendell, Johanna;
Sharma, Sunil;
Patel, Manish R.;
Windsor, Kevin S.;
Wainberg, Zev A.;
Gordon, Michael;
Chaves, Jorge;
Berlin, Jordan;
Brachmann, Carrie Baker;
Zavodovskaya, Marianna;
Liu, JieJane;
Thai, Dung;
Bhargava, Pankaj;
Shah, Manish A.;
Khan, Saad A.;
Starodub, Alexander

Publication type:

Article

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).

Published in:

Oncologist, 2020, v. 25, n. 3, p. e451, doi. 10.1634/theoncologist.2019-0291

By:

Bendell, Johanna C.;
Sauri, Tamara;
Gracián, Antonio Cubillo;
Alvarez, Rafael;
López‐López, Carlos;
García‐Alfonso, Pilar;
Hussein, Maen;
Miron, Maria‐Luisa Limon;
Cervantes, Andrés;
Montagut, Clara;
Vivas, Cristina Santos;
Bessudo, Alberto;
Plezia, Patricia;
Moons, Veerle;
Andel, Johannes;
Bennouna, Jaafar;
Westhuizen, Andre;
Samuel, Leslie;
Rossomanno, Simona;
Boetsch, Christophe

Publication type:

Article

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM).

Published in:

Oncologist, 2019, v. 24, n. 7, p. 921, doi. 10.1634/theoncologist.2018-0344

By:

Hurwitz, Herbert I.;
Tan, Benjamin R.;
Reeves, James A.;
Xiong, Henry;
Somer, Brad;
Lenz, Heinz‐Josef;
Hochster, Howard S.;
Scappaticci, Frank;
Palma, John F.;
Price, Richard;
Lee, John J.;
Nicholas, Alan;
Sommer, Nicolas;
Bendell, Johanna

Publication type:

Article

Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors.

Published in:

Oncologist, 2019, v. 24, n. 4, p. 455, doi. 10.1634/theoncologist.2018-0740

By:

Bendell, Johanna C.;
Patel, Manish R.;
Moore, Kathleen N.;
Chua, Cynthia C.;
Arkenau, Hendrik‐Tobias;
Dukart, Gary;
Harrow, Kim;
Liang, Chris

Publication type:

Article

A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.

Published in:

Oncologist, 2017, v. 22, n. 12, p. 1427, doi. 10.1634/theoncologist.2017-0066

By:

Ko, Andrew H.;
Murphy, Patrick B.;
Peyton, James D.;
Shipley, Dianna L.;
Al‐Hazzouri, Ahmed;
Rodriguez, Francisco A.;
Womack, Mark S.;
Xiong, Henry Q.;
Waterhouse, David M.;
Tempero, Margaret A.;
Guo, Shuangli;
Lane, Cassie M.;
Earwood, Chris;
DeBusk, Laura M.;
Bendell, Johanna C.

Publication type:

Article

A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.

Published in:

Oncologist, 2017, v. 22, n. 10, p. 1152, doi. 10.1634/theoncologist.2017-0186

By:

Shepard, Gregg;
Arrowsmith, Edward R.;
Murphy, Patrick;
Barton, John H.;
Peyton, James D.;
Mainwaring, Mark;
Blakely, Laura;
Maun, Noel A.;
Bendell, Johanna C.

Publication type:

Article

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRASMutant Colorectal Adenocarcinoma.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 243, doi. 10.1634/theoncologist.2016-0479

By:

Hecht, J. Randolph;
Benson, Al B.;
Vyushkov, Dmitry;
Yang, Yingsi;
Bendell, Johanna;
Verma, Udit

Publication type:

Article

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 241, doi. 10.1634/theoncologist.2017-0024

By:

Benson, Al B.;
Wainberg, Zev A.;
Hecht, J. Randolph;
Vyushkov, Dmitry;
Dong, Hua;
Bendell, Johanna;
Kudrik, Fred

Publication type:

Article

A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223

By:

Bendell, Johanna C.;
Hochster, Howard;
Hart, Lowell L.;
Firdaus, Irfan;
Mace, Joseph R.;
McFarlane, Joshua J.;
Kozloff, Mark;
Catenacci, Daniel;
Hsu, Jessie J.;
Hack, Stephen P.;
Shames, David S.;
Phan, See‐Chun;
Koeppen, Hartmut;
Cohn, Allen L.

Publication type:

Article

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.

Published in:

Oncologist, 2016, v. 21, n. 3, p. 279, doi. 10.1634/theoncologist.2015-0439

By:

Bendell, Johanna C.;
Zakari, Ahmed;
Peyton, James D.;
Boccia, Ralph;
Moskowitz, Mark;
Gian, Victor;
Lipman, Andrew;
Waterhouse, David;
LoCicero, Richard;
Earwood, Chris;
Lane, Cassie M.;
Meluch, Anthony

Publication type:

Article

Relative Bioavailability of Pediatric Oral Solution and Tablet Formulations of Trametinib in Adult Patients With Solid Tumors.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 287, doi. 10.1002/cpdd.152

By:

Cox, Donna S.;
Allred, Alicia;
Zhou, YanYan;
Infante, Jeffrey R.;
Gordon, Michael S.;
Bendell, Johanna;
Jones, Suzanne;
Burris, Howard;
Orford, Keith

Publication type:

Article

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors.

Published in:

Journal of Hematology & Oncology, 2011, v. 4, n. 1, p. 29, doi. 10.1186/1756-8722-4-29

By:

Kulke, Matthew H.;
Bendell, Johanna;
Kvols, Larry;
Picus, Joel;
Pommier, Rodney;
Yao, James

Publication type:

Article

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

Published in:

2020

By:

Martin-Liberal, Juan;
Hollebecque, Antoine;
Aftimos, Philippe;
Jungels, Christiane;
Martin-Romano, Patricia;
Rodon, Jordi;
Kremer, Jill Dolores;
Zhang, Wei;
Bendell, Johanna

Publication type:

journal article

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.

Published in:

2018

By:

Yokota, Tomoya;
Bendell, Johanna;
LoRusso, Patricia;
Tsushima, Takahiro;
Desai, Ved;
Kenmotsu, Hirotsugu;
Watanabe, Junichiro;
Ono, Akira;
Murugesan, Bhavani;
Silva, Joseph;
Naito, Tateaki;
Greenberg, Jonathan;
Kumar, Prasanna;
Wang, Yibin;
Jikoh, Takahiro;
Shiga, Ryota;
Hyman, David M.;
Ho, Alan Loh;
Spriggs, David R.;
Schwartz, Gary K.

Publication type:

journal article

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.

Published in:

2017

By:

Bendell, Johanna C;
Javle, Milind;
Bekaii-Saab, Tanios S;
Finn, Richard S;
Wainberg, Zev A;
Laheru, Daniel A;
Weekes, Colin D;
Tan, Benjamin R;
Khan, Gazala N;
Zalupski, Mark M;
Infante, Jeffrey R;
Jones, Suzanne;
Papadopoulos, Kyriakos P;
Tolcher, Anthony W;
Chavira, Renae E;
Christy-Bittel, Janna L;
Barrett, Emma;
Patnaik, Amita

Publication type:

journal article

Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2073, doi. 10.1007/s00228-013-1580-y

By:

Wu, Huali;
Infante, Jeffrey R.;
Keedy, Vicki L.;
Jones, Suzanne F.;
Chan, Emily;
Bendell, Johanna C.;
Lee, Wooin;
Zamboni, Beth A.;
Ikeda, Satoshi;
Kodaira, Hiroshi;
Rothenberg, Mace L.;
Burris III, Howard A.;
Zamboni, William C.

Publication type:

Article

A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas.

Published in:

Oncologist, 2013, v. 18, n. 3, p. 271, doi. 10.1634/theoncologist.2012-0404

By:

Uronis, Hope E.;
Bendell, Johanna C.;
Altomare, Ivy;
Blobe, Gerard C.;
Hsu, S. David;
Morse, Michael A.;
Pang, Herbert;
Zafar, S. Yousuf;
Conkling, Paul;
Favaro, Justin;
Arrowood, Christy C.;
Cushman, Stephanie M.;
Meadows, Kellen L.;
Brady, John C.;
Nixon, Andrew B.;
Hurwitz, Herbert I.

Publication type:

Article

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study.

Published in:

Oncologist, 2012, v. 17, n. 12, p. 1486, doi. 10.1634/theoncologist.2012-0190

By:

Bendell, Johanna C.;
Bekaii-Saab, Tanios S.;
Cohn, Allen L.;
Hurwitz, Herbert I.;
Kozloff, Mark;
Tezcan, Haluk;
Roach, Nancy;
Mun, Yong;
Fish, Susan;
Flick, E. Dawn;
Dalal, Darshan;
Grothey, Axel

Publication type:

Article

A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer.

Published in:

Oncologist, 2011, v. 16, n. 8, p. 1131, doi. 10.1634/theoncologist.2011-0078

By:

ALTOMARE, IVY;
BENDELL, JOHANNA C.;
BULLOCK, KAREN E.;
URONIS, HOPE E.;
MORSE, MICHAEL A.;
HSU, S. DAVID;
ZAFAR, S. YOUSUF;
BLOBE, GERARD C.;
PANG, HERBERT;
HONEYCUTT, WANDA;
SUTTON, LINDA;
HURWITZ, HERBERT I.

Publication type:

Article

Anal Cancer: An Overview.

Published in:

Oncologist, 2007, v. 12, n. 5, p. 524, doi. 10.1634/theoncologist.12-5-524

By:

Uronis, Hope E.;
Bendell, Johanna C.

Publication type:

Article

A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer.

Published in:

Cancer Medicine, 2021, v. 10, n. 4, p. 1183, doi. 10.1002/cam4.3630

By:

Patel, Manish R.;
Falchook, Gerald S.;
Hamada, Kensuke;
Makris, Lukas;
Bendell, Johanna C.

Publication type:

Article

A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.

Published in:

Cancer Medicine, 2019, v. 8, n. 11, p. 5148, doi. 10.1002/cam4.2425

By:

Hu, Zishuo Ian;
Bendell, Johanna C.;
Bullock, Andrea;
LoConte, Noelle K.;
Hatoum, Hassan;
Ritch, Paul;
Hool, Hugo;
Leach, Joseph W.;
Sanchez, James;
Sohal, Davendra P. S.;
Strickler, John;
Patel, Ravindranath;
Wang‐Gillam, Andrea;
Firdaus, Irfan;
Yu, Kenneth H.;
Kapoun, Ann M.;
Holmgren, Eric;
Zhou, Lei;
Dupont, Jakob;
Picozzi, Vincent

Publication type:

Article

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.

Published in:

Cancer Medicine, 2018, v. 7, n. 11, p. 5382, doi. 10.1002/cam4.1703

By:

Fogelman, David;
Cubillo, Antonio;
García‐Alfonso, Pilar;
Mirón, María Luisa Limón;
Nemunaitis, John;
Flora, Daniel;
Borg, Christophe;
Mineur, Laurent;
Vieitez, Jose M.;
Cohn, Allen;
Saylors, Gene;
Assad, Albert;
Switzky, Julie;
Zhou, Li;
Bendell, Johanna

Publication type:

Article

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.

Published in:

PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994

By:

Wolin, Edward;
Mita, Alain;
Mahipal, Amit;
Meyer, Tim;
Bendell, Johanna;
Nemunaitis, John;
Munster, Pam N.;
Paz-Ares, Luis;
Filvaroff, Ellen H.;
Li, Shaoyi;
Hege, Kristen;
de Haan, Hans;
Mita, Monica

Publication type:

Article

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.

Published in:

2019

By:

Mettu, Niharika B.;
Niedzwiecki, Donna;
Rushing, Christel;
Nixon, Andrew B.;
Jia, Jingquan;
Haley, Sherri;
Honeycutt, Wanda;
Hurwitz, Herbert;
Bendell, Johanna C.;
Uronis, Hope

Publication type:

journal article

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 343, doi. 10.1007/s00280-014-2647-x

By:

Uronis, Hope;
Jia, Jingquan;
Bendell, Johanna;
Howard, Leigh;
Ready, Neal;
Lee, Paula;
Starr, Mark;
Dellinger, Andrew;
Pang, Herbert;
Nixon, Andrew;
Hurwitz, Herbert

Publication type:

Article

Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 125, doi. 10.1007/s00280-014-2480-2

By:

Bendell, Johanna;
Hong, David;
Burris, Howard;
Naing, Aung;
Jones, Suzanne;
Falchook, Gerald;
Bricmont, Patricia;
Elekes, Agnes;
Rock, Edwin;
Kurzrock, Razelle

Publication type:

Article

Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 699, doi. 10.1007/s00280-012-1960-5

By:

Infante, Jeffrey;
Keedy, Vicki;
Jones, Suzanne;
Zamboni, William;
Chan, Emily;
Bendell, Johanna;
Lee, Wooin;
Wu, Huali;
Ikeda, Satoshi;
Kodaira, Hiroshi;
Rothenberg, Mace;
Burris III, Howard

Publication type:

Article

A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors.

Published in:

2012

By:

Jones, Suzanne;
Infante, Jeffrey;
Thompson, Dana;
Mohyuddin, Adil;
Bendell, Johanna;
Yardley, Denise;
Burris, Howard

Publication type:

Report

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 95, doi. 10.1007/s00280-012-1889-8

By:

Vlahovic, Gordana;
Meadows, Kellen;
Uronis, Hope;
Morse, Michael;
Blobe, Gerard;
Riedel, Richard;
Zafar, S.;
Alvarez-Secord, Angeles;
Gockerman, Jon;
Starodub, Alexander;
Ready, Neal;
Anderson, Elizabeth;
Bendell, Johanna;
Hurwitz, Herbert

Publication type:

Article

A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 137, doi. 10.1007/s00280-011-1674-0

By:

Infante, Jeffrey;
Jones, Suzanne;
Bendell, Johanna;
Greco, F.;
Yardley, Denise;
Lane, Cassie;
Spigel, David;
Hainsworth, John;
Burris III, Howard

Publication type:

Article

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).

Published in:

2011

By:

Bullock, Karen;
Petros, William;
Younis, Islam;
Uronis, Hope;
Morse, Michael;
Blobe, Gerard;
Yousuf Zafar, S.;
Gockerman, Jon;
Lager, Joanne;
Truax, Roxanne;
Meadows, Kellen;
Howard, Leigh;
O'Neill, Margot;
Broadwater, Gloria;
Hurwitz, Herbert;
Bendell, Johanna

Publication type:

Report

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 569, doi. 10.1007/s11523-021-00835-0

By:

Moore, Kathleen N.;
Hong, David S.;
Patel, Manish R.;
Pant, Shubham;
Ulahannan, Susanna V.;
Jones, Suzanne;
Meric-Bernstam, Funda;
Wang, Judy S.;
Aljumaily, Raid;
Hamilton, Erika P.;
Wittchen, Erika S.;
Wang, Xuejing;
Lin, Aimee Bence;
Bendell, Johanna C.

Publication type:

Article

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 4, p. 340, doi. 10.4161/cbt.23625

By:

Infante, Jeffrey R.;
Arkenau, Hendrik-Tobias;
Bendell, Johanna C.;
Rubin, Mark S.;
Waterhouse, David;
Jones, George Tripp;
Spigel, David R.;
Lane, Cassie M.;
Hainsworth, John D.;
Burris III, Howard A.

Publication type:

Article

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.

Published in:

2020

By:

Wainberg, Zev A.;
Feeney, Kynan;
Lee, Myung Ah;
Muñoz, Andrés;
Gracián, Antonio Cubillo;
Lonardi, Sara;
Ryoo, Baek-Yeol;
Hung, Annie;
Lin, Yong;
Bendell, Johanna;
Hecht, J. Randolph

Publication type:

journal article

Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.

Published in:

Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 7, p. 726, doi. 10.1002/pds.3633

By:

Grothey, Axel;
Flick, E. Dawn;
Cohn, Allen L.;
Bekaii‐Saab, Tanios S.;
Bendell, Johanna C.;
Kozloff, Mark;
Roach, Nancy;
Mun, Yong;
Fish, Susan;
Hurwitz, Herbert I.

Publication type:

Article

Regorafenib Prior to Selective Internal Radiation Therapy Using <sup>90</sup>Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.

Published in:

Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00624

By:

Kennedy, Andrew;
Shipley, Dianna;
Shpak, Max;
Blakely, Laura;
Hemphill, Brian;
Shih, Kent;
Lane, Cassie;
Zimmerman, Lisa;
McKenzie, Andrew;
Mainwaring, Mark;
Peyton, James D.;
Zubkus, John;
Wright, David;
Singh, Jaswinder;
Bendell, Johanna C.

Publication type:

Article

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41618-7

By:

Taraborrelli, Lucia;
Şenbabaoğlu, Yasin;
Wang, Lifen;
Lim, Junghyun;
Blake, Kerrigan;
Kljavin, Noelyn;
Gierke, Sarah;
Scherl, Alexis;
Ziai, James;
McNamara, Erin;
Owyong, Mark;
Rao, Shilpa;
Calviello, Aslihan Karabacak;
Oreper, Daniel;
Jhunjhunwala, Suchit;
Argiles, Guillem;
Bendell, Johanna;
Kim, Tae Won;
Ciardiello, Fortunato;
Wongchenko, Matthew J.

Publication type:

Article

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

Published in:

Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985

By:

Chau, Ian;
Penel, Nicolas;
Soriano, Andres O.;
Arkenau, Hendrik-Tobias;
Cultrera, Jennifer;
Santana-Davila, Rafael;
Calvo, Emiliano;
Le Tourneau, Christophe;
Zender, Lars;
Bendell, Johanna C.;
Mi, Gu;
Gao, Ling;
McNeely, Samuel Clark;
Oliveira, Joana M.;
Ferry, David;
Herbst, Roy S.;
Fuchs, Charles S.

Publication type:

Article

Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.

Published in:

Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002

By:

Shah, Manish A.;
Takayuki Yoshino;
Tebbutt, Niall C.;
Grothey, Axel;
Tabernero, Josep;
Rui-Hua Xu;
Cervantes, Andres;
Sang Cheul Oh;
Kensei Yamaguchi;
Fakih, Marwan;
Falcone, Alfredo;
Christina Wu;
Chiu, Vi K.;
Tomasek, Jiri;
Bendell, Johanna;
Fontaine, Marilyn;
Hitron, Matthew;
Bo Xu;
Taieb, Julien;
Van Cutsem, Eric

Publication type:

Article

Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study.

Published in:

Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 239, doi. 10.1016/j.clcc.2013.09.001

By:

Bendell, Johanna C.;
Tourmgand, Christophe;
Swieboda-Sadlej, Anna;
Barone, Carlo;
Wainberg, Zev A.;
Jong Gwang Kim;
Pencay, Carles;
Pastorelli, Davide;
Tarazi, Jamal;
Rosbrook, Brad;
Bloom, Joanna;
Ricart, Alejandro D.;
Kim, Sinil;
Sobrero, Alberto F.

Publication type:

Article